News & Updates

Quarterly Newsletter January 2022 Edition: PREVENT Study Issue 8
Laveena Noronha Laveena Noronha

Quarterly Newsletter January 2022 Edition: PREVENT Study Issue 8

The PREVENT study aims to prevent epilepsy caused by neonatal encephalopathy in India by implementation of a pragmatic intrapartum care bundle. The first phase of the study has been completed effectively, and we are now moving on to the second phase. During the transition period, we arranged a virtual meeting to examine the challenges of implementing the care bundle and come up with the best approach to combat them.

Simultaneously, we conducted Basic Neonatal Resuscitation Programme and dignity games across all sites. Following that, we held a virtual symposium on "Saving Babies Brains," which was a crucial milestone during the transition period.

So far, we have enrolled 40,453 moms and 797 infants for the study. The The PREVENT study encourages its employees to enhance professional skills; as a result, we are pleased to inform that one of our teammate (GHR SPARC awardee) got the opportunity to present her career journey at an NIHR webinar.

Throughout the transition phase, we also had new team members joining the PREVENT team.

Read More